PHAR 6-K SEC Filing Analysis

Latest settled — T+20d

PHAR ▼ -25.16% at T+20d

NEUTRAL call ✗ call lost -25.16% · α vs SPY -30.97% · entry $17.33 → $12.97

Next anchor: T+60d in 4w

Currently $12.81 · -26.11% from $17.33 entry

Entry anchored
Apr 15, 02:00 PM ET
via Databento tick

T+1d

+0.06%

call +0.06% · α -1.16%

$17.34

settled 8w ago

T+5d

-3.98%

call -3.98% · α -4.97%

$16.64

settled 7w ago

T+20d

-25.16%

call -25.16% · α -30.97%

$12.97

settled 4w ago

T+60d

—

call — · α —

—

in 4w

Price Chart

Loading chart...

Executive Summary

Pharming Group N.V. announced the date and agenda for its 2026 Annual General Meeting of Shareholders (AGM). The meeting will include proposals to appoint KPMG N.V. as auditor, amend non-executive director fees, and renew authorizations for share issuance and repurchase. This is a routine corporate governance filing.

Actionable Insight

This is a routine governance announcement. Traders should note the AGM date and agenda, but no immediate trading action is warranted based on this filing alone. Monitor for any unexpected developments during the actual meeting.

Key Facts

Pharming Group N.V. announced its 2026 Annual General Meeting of Shareholders (AGM) will be held on May 28, 2026.
The AGM agenda includes appointing KPMG N.V. as external auditor for 2026-2028.
The agenda includes proposals to amend fees for Non-Executive Directors.
The agenda includes renewing authorizations for the Board to issue and repurchase shares.

Financial Impact

The filing contains no new financial data. The share issuance and repurchase authorizations are routine renewals.

Risk Factors

Routine filing with no material financial risk disclosed.

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

Document	Accession Number
6-K Filing (Primary)	0001828316-26-000021
Document: 0001828316-26-000021-index-headers.html	0001828316-26-000021
Document: 0001828316-26-000021-index.html	0001828316-26-000021
Document: 0001828316-26-000021.txt	0001828316-26-000021

5 reports for PHAR

T+1T+5T+20T+60

67% Hit rate 2 of 3 directional calls best @ T+20▲ +3.74%Mar 27, 2026

Filters

Reports for PHAR — sortable, filterable
	Type				Now
Jun 4, 2026 9d ago	6-K BULLISH ★ 7/10	$12.47 $12.54	▲ +0.57%	▲ +3.17%	$12.81 (+2.69%)
May 28, 2026 15d ago	6-K NEUTRAL ★ 3/10	$13.66 $12.99	▼ −4.90%	▼ −5.14%	$12.81 (−6.26%)
May 22, 2026 21d ago	6-K BULLISH ★ 7/10	$13.62 $13.41	▼ −1.54%	▼ −1.55%	$12.81 (−5.98%)
Apr 16, 2026 8w ago	6-K NEUTRAL ★ 3/10	$17.33 $17.34	▲ +0.06%	▼ −1.16%	$12.81 (−26.11%)
Mar 27, 2026 11w ago	6-K BULLISH ★ 8/10	$16.31 $16.01	▼ −1.84%	▼ −1.48%	$12.81 (−21.49%)

US Market Status

Market Closed — Opens Mon (46h 59m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access